Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Assessing ADMA Biologics (ADMA) Valuation After Fresh Analyst Upgrades And Strong Buy Sentiment
Analyst sentiment for ADMA Biologics (ADMA) has improved, leading to a consensus Strong Buy rating despite recent share price declines. The stock appears undervalued based on an estimated intrinsic value and analyst price targets, with one narrative suggesting a fair value of $20.93. However, a contrasting view based on market ratios indicates a richer price, with its P/E ratio exceeding industry averages, suggesting expectations are already priced in.